Belgium telecommunications company BICS to buy TeleSign for $230 million, in-home clinical trial software startup Science 37 raises $29 million, and Soylent recalls powder after accidental mixing with whey.
TeleSign Corp. of Marina del Rey, a developer of user authentication software, announced on Tuesday that it had agreed to be acquired for $230 million in cash by telecommunications company BICS of Belgium. The deal is expected to close in the third quarter of this year after regulatory review.
In-home clinical trial software startup Science 37 Inc. raised $29 million, reports TechCrunch. Science 37’s software allows patients to participate in clinical studies in their homes and on their own time instead of through a doctor’s office.
Soylent voluntarily recalled 890 boxes of its powder meal replacement after it accidentally mixed with whey protein, reports Ars Technica. On its recall notification on the Food and Drug Administration’s website, the company wrote that it has not received any reports of illnesses related to the whey.
For reprint and licensing requests for this article, CLICK HERE.
Stories You May Also Be Interested In
- Belgium Telecom Company BICS to Buy TeleSign for $230 Million
- TeleSign Appoints Co-Founder Disraeli as Chief Executive
- Account Security Firm Signs Off on Sale for $230 Million
- Silicon Beach Report March 7: TeleSign Selects New CEO
- Silicon Beach Report Oct. 31: Elon Musk Says Boring Co. Tunnel Should Be 17 Miles Long in One Year
- Silicon Beach Report Dec. 16: Riot Signs $300M Internet Broadcasting Deal for ‘League of Legends’
- Silicon Beach Report Oct. 28: Six Senior Execs Leave Faraday Future
- Soylent Banned from Canada